Category Archives: FDA Press Releases

FDA Approves First Fecal Microbiota Product

By | FDA Press Releases | No Comments

FDA approves the first fecal microbiota product, Rebyota. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. It is for used after an individual has completed antibiotic treatment for recurrent CDI.
Source: FDA Press Releases